132 Participants Needed

LifeVac, Dechoker, and Abdominal Thrusts for Choking

CD
Overseen ByCody Dunne, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Calgary
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

WHY IS THIS STUDY BEING DONE? Little is known about the best treatment for choking. New airway clearance devices like LifeVac© and Dechoker© are being sold to help a choking person. Researchers do not know how well they work compared to other techniques like abdominal thrusts or back blows. The purpose of this research study is to see how well bystanders can use the choking techniques. RESEARCH QUESTION Among laypersons, which FBAO intervention (abdominal thrusts, LifeVac©, or Dechoker©) results in the greatest proportion of FBAO relief within one-minute? PARTICIPANTS Adults aged 18 years or greater. INTERVENTIONS View a video of each choking intervention, and then complete a choking scenario where participants will try to relieve an airway obstruction on a simulation mannequin. The three interventions are: LifeVac, Dechoker, and Abdominal Thrusts. Participants will be invited back between 90-120 days to repeat the scenarios to assess retention.

Do I need to stop taking my current medications to join the trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Abdominal Thrusts, Dechoker, LifeVac for choking?

Research shows that the DeChoker device successfully removed obstructions in 26 out of 27 choking cases in care homes, and the LifeVac device was effective in 38 out of 39 choking emergencies in patients with swallowing difficulties. Abdominal thrusts, a traditional method, are known to increase chest pressure to help clear blockages.12345

Is the LifeVac and Dechoker safe for use in choking emergencies?

The LifeVac and Dechoker devices have been used in real-world choking emergencies with minimal reported complications. Studies show they are generally safe, with successful outcomes in most cases and few adverse events.12346

How does the treatment for choking using LifeVac, Dechoker, and Abdominal Thrusts differ from other treatments?

The treatment for choking using LifeVac, Dechoker, and Abdominal Thrusts is unique because it combines mechanical devices (LifeVac and Dechoker) with a physical technique (Abdominal Thrusts) to clear airway obstructions. This approach offers a non-invasive alternative to traditional methods, potentially increasing effectiveness and safety in emergency situations.7891011

Eligibility Criteria

This study is for adults aged 18 or older who can communicate in English. It's designed to evaluate how well people can use different choking relief techniques, such as LifeVac, Dechoker, and abdominal thrusts on a simulation mannequin after watching an instructional video.

Inclusion Criteria

I can communicate in English to sign informed consent.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Pre-simulation Orientation

Participants receive an orientation to the simulator and environment, and are briefed on the outcomes being assessed.

1 day
1 visit (in-person)

Intervention

Participants view educational videos and perform choking interventions on a simulation mannequin using LifeVac, Dechoker, and Abdominal Thrusts.

1 day
1 visit (in-person)

Follow-up

Participants are invited back to repeat the scenarios to assess skills retention.

90-120 days
1 visit (in-person)

Treatment Details

Interventions

  • Abdominal Thrusts
  • Dechoker
  • LifeVac
Trial Overview The trial tests three interventions for relieving airway obstruction: LifeVac, Dechoker, and traditional abdominal thrusts. Participants will watch a video demonstration of each technique before attempting to clear a blockage on a mannequin. They'll be retested after 90-120 days to see if they remember the techniques.
Participant Groups
6Treatment groups
Experimental Treatment
Group I: LV - DC - ATExperimental Treatment3 Interventions
Order: LifeVac then Dechoker then Abdominal Thrusts
Group II: LV - AT - DCExperimental Treatment3 Interventions
Order: LifeVac then Abdominal Thrusts then Dechoker
Group III: DC - LV - ATExperimental Treatment3 Interventions
Order: Dechoker then LifeVac then Abdominal Thrusts
Group IV: DC - AT - LVExperimental Treatment3 Interventions
Order: Dechoker then Abdominal Thrusts then LifeVac
Group V: AT - LV - DCExperimental Treatment3 Interventions
Order: Abdominal Thrusts then LifeVac then Dechoker
Group VI: AT - DC - LVExperimental Treatment3 Interventions
Order: Abdominal Thrusts then Dechoker then LifeVac

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Calgary

Lead Sponsor

Trials
827
Recruited
902,000+

Canadian Association of Emergency Physicians

Industry Sponsor

Trials
9
Recruited
1,000+

Findings from Research

Untrained health science students were able to effectively use the LifeVac® and DeCHOKER® anti-choking devices in simulated choking scenarios, achieving compliance rates between 80-100%.
The LifeVac® device was significantly faster to use than the DeCHOKER®, with an average completion time of 36.6 seconds compared to 50.4 seconds, suggesting it may be more efficient in emergency situations.
Would anti-choking devices be correctly and quickly managed by health science students? A manikin crossover trial.Cardalda-Serantes, B., Carballo-Fazanes, A., Rodríguez-Ruiz, E., et al.[2023]
In a study involving 27 choking incidents in UK adult care homes, the DeChoker Airway Clearance Device successfully removed obstructions in 26 cases, demonstrating high efficacy with minimal complications.
Care home staff reported that the DeChoker was easy to use and effective, with 78% of victims not needing to visit Accident and Emergency, suggesting it could be a valuable tool in managing choking emergencies, especially for individuals with limited mobility.
Evaluation of DeChoker, an Airway Clearance Device (ACD) Used in Adult Choking Emergencies Within the Adult Care Home Sector: A Mixed Methods Case Study.Bhanderi, BG., Palmer Hill, S.[2023]
Airway clearance devices (ACDs) like LifeVac and Dechoker have shown promise in resolving choking symptoms, with successful outcomes reported in 123 cases for LifeVac and 60 cases for Dechoker among a total of 185 interventions.
The use of ACDs resulted in a low incidence of adverse events (1.6%), indicating they are generally safe, but further independent studies are needed to enhance data quality and refine choking intervention protocols.
Phase One of a Global Evaluation of Suction-Based Airway Clearance Devices in Foreign Body Airway Obstructions: A Retrospective Descriptive Analysis.Dunne, CL., Osman, S., Viguers, K., et al.[2023]

References

Would anti-choking devices be correctly and quickly managed by health science students? A manikin crossover trial. [2023]
Evaluation of DeChoker, an Airway Clearance Device (ACD) Used in Adult Choking Emergencies Within the Adult Care Home Sector: A Mixed Methods Case Study. [2023]
Phase One of a Global Evaluation of Suction-Based Airway Clearance Devices in Foreign Body Airway Obstructions: A Retrospective Descriptive Analysis. [2023]
Use of a Novel Portable Non-powered Suction Device in Patients With Oropharyngeal Dysphagia During a Choking Emergency. [2022]
Choking on a foreign body: a physiological study of the effectiveness of abdominal thrust manoeuvres to increase thoracic pressure. [2022]
The efficacy of two commercially available devices for airway foreign body relief: A cadaver study. [2023]
Decarbonylative Phosphorylation of Carboxylic Acids via Redox-Neutral Palladium Catalysis. [2022]
Highly effective copper-catalyzed decarboxylative coupling of aryl halides with alkynyl carboxylic acids. [2013]
Copper-catalyzed aerobic decarboxylative coupling between cyclic α-amino acids and diverse C-H nucleophiles with low catalyst loading. [2022]
One-pot formation of 2,4-di- or 2,4,6-tri-olefinic monocarboxylic acids by straight chain C4-extension. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Kinetically Controllable Construction of Nine-Membered Carbocycles via Pd-Catalyzed Decarboxylative Cycloaddition. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security